1 story in the last 7 days
The latest glp-1 news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks glp-1 across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
The Wegovy pill continues to dominate the GLP-1 pill market. Novo Nordisk's oral formulation maintains a strong lead over competitors in the growing class of weight loss medications. The pill form offers an alternative to injections for patients seeking obesity treatment. Market data shows Wegovy's oral version capturing significant share among GLP-1 receptor agonist pills.
Summaries by ByteBrief